Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aclaris Therapeutics

1.44
+0.06004.35%
Post-market: 1.440.00000.00%16:18 EDT
Volume:668.87K
Turnover:945.71K
Market Cap:155.92M
PE:-0.84
High:1.46
Open:1.40
Low:1.37
Close:1.38
Loading ...
Dec 12, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 11, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Nov 25, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 13, 2023

Major Issues Report

Form 8-K - Current report
Nov 06, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2023

Major Issues Report

Form 8-K - Current report
Oct 24, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 18, 2023

Major Issues Report

Form 8-K - Current report
Sep 05, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Aug 21, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2023

Major Issues Report

Form 8-K - Current report
Jun 20, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 13, 2023

Major Issues Report

Form 8-K - Current report
Jun 02, 2023

Major Issues Report

Form 8-K - Current report
Jun 01, 2023

Major Issues Report

Form 8-K - Current report
May 08, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 08, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2023

Major Issues Report

8-K - Current report
Apr 14, 2023

Major Issues Report

8-K - Current report